Microplastics Pose Growing Threat to Heart Health

by DR. RITU APARAJITA, KSC Cardiology

Microplastics and nanoplastics are increasing your cardiovascular risk.

The production of plastics is constantly increasing and this is set to continue through 2050. Plastics can pollute the environment by way of ocean currents, atmospheric winds and terrestrial phenomena, contributing to their widespread distribution. Once released into nature, plastics are susceptible to degradation, leading to the formation of microplastics, defined as particles smaller than 5 mm, and nanoplastics, defined as particles smaller than 1000 nanometers. Both types of particles trigger a range of toxic effects.

Several research studies have shown that microplastics and nanoplastics (MNPs) enter the human body through eating, breathing, and skin exposure, where they interact with tissues and organs. MNPs have been found in selected human tissues, such as the placenta, lungs, and liver, as well as in breastmilk, urine, and blood. Recent studies performed in preclinical settings have led to the suggestion of MNPs as a new risk factor for cardiovascular diseases. They do this by promoting oxidative stress, inflammation, and programmed cell death in endothelial and other vascular cells in the blood vessels. Studies done in animals showed that MNPs change the heart rate and cause impairment of heart function, fibrosis in heart muscles, and remote dysfunction of blood vessel cells.

Recent studies have shown there is an association between the burden of MNPs and cardiovascular disease. Atherosclerotic plaque was detected in surgical samples from the carotid artery. Subsequent studies confirmed that patients with MNPs in the plaque in their carotid artery had a higher risk of having a heart attack, stroke, or death from any cause compared to patients whose carotid artery sample did not have MNPs in the plaque.

BIO: Dr. Aparajita is a fellowship-trained vascular and endovascular surgeon. She is a co-author of 20-plus journal articles and publications and was recently nominated for an Inspiration Award by the American Medical Association.

This column is sponsored by KSC Cardiology, and the opinions expressed herein may not reflect those of CFHN or its advertisers.